FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
This Quarter Return
+20.37%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$20.2B
AUM Growth
+$20.2B
(+8.8%)
Cap. Flow
-$834M
Cap. Flow
% of AUM
-4.14%
Top 10 Holdings %
Top 10 Hldgs %
41.49%
Holding
507
New
64
Increased
168
Reduced
186
Closed
63
Top Buys
| 1 |
Micron Technology
MU
|
$152M |
| 2 |
Stryker
SYK
|
$102M |
| 3 |
Netflix
NFLX
|
$92.2M |
| 4 |
Mobileye
MBLY
|
$73.1M |
| 5 |
Citigroup
C
|
$69.2M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$206M |
| 2 |
UnitedHealth
UNH
|
$136M |
| 3 |
Apple
AAPL
|
$106M |
| 4 |
Transmedics
TMDX
|
$99.2M |
| 5 |
ServiceNow
NOW
|
$82.3M |
Sector Composition
| 1 | Technology | 39.23% |
| 2 | Healthcare | 17.27% |
| 3 | Consumer Discretionary | 11.73% |
| 4 | Communication Services | 11.02% |
| 5 | Industrials | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Celsius Holdings
CELH
$15.8B
| $54.6M | 0.27% |
658,429
+87,934
| +15% | +$7.29M |
|
77
Clearwater Analytics
CWAN
$5.91B
| $54.2M | 0.27% |
3,064,258
-57,891
| -2% | -$1.02M |
|
78
Q2 Holdings
QTWO
$4.83B
| $53.3M | 0.26% |
1,013,887
-4,827
| -0.5% | -$254K |
|
79
Cabaletta Bio
CABA
$144M
| $53.1M | 0.26% |
3,110,314
-216,818
| -7% | -$3.7M |
|
80
Tandem Diabetes Care
TNDM
$834M
| $53M | 0.26% |
1,497,071
+1,194,292
| +394% | +$42.3M |
|
81
Walmart
WMT
$793B
| $50M | 0.25% |
830,320
+807,706
| +3,572% | +$45.9M |
|
82
Eaton
ETN
$134B
| $49.7M | 0.25% |
158,913
-27,815
| -15% | -$8.7M |
|
83
Kura Sushi USA
KRUS
$1.02B
| $49.7M | 0.25% |
431,294
+69,578
| +19% | +$8.01M |
|
84
Inspire Medical Systems
INSP
$2.53B
| $47.8M | 0.24% |
222,560
-183,347
| -45% | -$39.4M |
|
85
Montrose Environmental
MEG
$1.01B
| $46.5M | 0.23% |
1,186,911
+232,553
| +24% | +$9.11M |
|
86
Regeneron Pharmaceuticals
REGN
$59.8B
| $46.2M | 0.23% |
48,001
-2,596
| -5% | -$2.5M |
|
87
Rambus
RMBS
$7.93B
| $44.5M | 0.22% |
719,773
-3,186
| -0.4% | -$197K |
|
|
88
UnitedHealth
UNH
$279B
| $44.1M | 0.22% |
89,077
-274,368
| -75% | -$136M |
|
89
Strategy Inc Common Stock Class A
MSTR
$93.6B
| $43.3M | 0.21% |
+25,381
| New | +$43.3M |
|
90
Sprout Social
SPT
$896M
| $43M | 0.21% |
719,810
+370
| +0.1% | +$22.1K |
|
91
Intapp
INTA
$3.63B
| $42.4M | 0.21% |
1,236,543
+276,077
| +29% | +$9.47M |
|
92
Trex
TREX
$6.41B
| $42.2M | 0.21% |
423,354
+48,948
| +13% | +$4.88M |
|
93
Absci
ABSI
$356M
| $42.1M | 0.21% |
+7,407,809
| New | +$42.1M |
|
94
Acadia Pharmaceuticals
ACAD
$4.34B
| $41.7M | 0.21% |
2,257,564
-919,211
| -29% | -$17M |
|
95
Manhattan Associates
MANH
$12.5B
| $41.6M | 0.21% |
166,380
-21,473
| -11% | -$5.37M |
|
96
Immunovant
IMVT
$2.91B
| $41.1M | 0.2% |
1,271,762
+386,890
| +44% | +$12.5M |
|
97
Nuvalent
NUVL
$5.74B
| $40.9M | 0.2% |
544,372
+222,420
| +69% | +$16.7M |
|
98
Amgen
AMGN
$153B
| $40.5M | 0.2% |
142,601
-286,906
| -67% | -$81.6M |
|
|
ALTR
99
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $40M | 0.2% |
464,512
+19,173
| +4% | +$1.65M |
|
100
Viking Therapeutics
VKTX
$3.02B
| $38.3M | 0.19% |
+467,216
| New | +$38.3M |
|